News

The study was conducted by Pew Research Centre, a US think-tank that says it is non-partisan, and is based in Washington DC. It sampled 24 countries. Findings show that the ratings of the US among ...
A new collab is coming to Among Us featuring various iconic characters from the Like a Dragon, aka Yakuza, series. The collaboration is set to start on March 26, 2025, and it will run in-game ...
Schell Games and Innersloth announced that flatscreen support is coming to Among Us VR (2022), which means crossplay for VR and PC players. Additionally, the studios announced the VR game is ...
Among Us 3D, a new version of the viral hit that took the gaming world by storm a few years back, finally has a release date. The game will be launching May 5, 2025, on Steam - so grab some crew ...
Among Us 3D is basically the same as the VR version, but adapts it for play without VR-style controls, and adds a HUD. Crossplay between Among Us 3D and the existing VR version will be possible ...
Innersloth also announced that Among Us VR is changing names in the coming months and will be renamed Among Us 3D. The studio also announced that it's launching a new in-game currency called ...
On June 15, 2018, Innersloth debuted Among Us on mobile before eventually bringing the game to consoles and PC. The game's seventh anniversary is coming up in a few days, and Innersloth is ...
METHODOLOGY: Researchers conducted a cross-sectional analysis using the Epic Cosmos electronic health records database, covering 1633 US hospitals and 78 million admissions from 2017 to 2024. The ...
Griselda Lopez Perez, ex-wife of convicted drug lord Joaquin "El Chapo" Guzman, and 16 other relatives entered the US Friday in a deal with the feds over the narcotrafficker's son.
Emergency meeting! Among Us 3D is coming to PC this May. Game developers InnerSloth and Schell Games have announced a release date for Among Us 3D: 6 May, 2025. The 3D version of the beloved social ...
Annual prevalence of GLP-1 RA use among US adults without diabetes increased from 0.1% in 2018-2021 to 0.4% in 2022, with an estimated 854,728 adults without diabetes taking these medications.